The popularity of Viagra initially drove a surge for major pharmaceutical companies, but recent developments present a uncertain outlook for shareholders. Lower-cost alternatives are reducing revenue, and ongoing https://macietdwj068972.articlesblogger.com/63569568/viagra-and-big-pharma-a-volatile-play